Back to Authors

Guo, Feng

0000-0001-9103-3235

Mayo Clinic

Indiana University Bloomington

Citations 2

Understanding monocyte-driven neuroinflammation in Alzheimer’s disease using human cortical organoid microphysiological systems
Tian, Chunhui , Ao, Zheng , Cerneckis, Jonas , Cai, Hongwei , Niu, Hengyao , Takayama, Kazuo , Kim, Jungsu , Shi, Yanhong , Gu, Mingxia , Kanekiyo, Takahisa , Niu, Hengyao , Takayama, Kazuo , Kim, Jungsu , Gu, Mingxia , Kanekiyo, Takahisa , Guo, Feng , Tian, Chunhui , Chen, Lei

Science Advances | August 22, 2025 | Volume: 11 | Issue: 34 | Pages: No page available

10.1126/sciadv.adu2708 Get It

Increasing evidence strongly links neuroinflammation to Alzheimer’s disease (AD) pathogenesis. Peripheral monocytes are crucial components of the human immune system, but their contribution to AD pathogenesis is still largely understudied partially due to limited human models. Here, we introduce human cortical organoid microphysiological systems (hCO-MPSs) to study AD monocyte-mediated neuroinflammation. By culturing doughnut-shape organoids on 3D-printed devices within standard 96-well plates, we generate hCO-MPSs with reduced necrosis, minimized hypoxia, and improved viability. Using these models, we found that monocytes from AD patients exhibit increased infiltration ability, decreased amyloid-β clearance capacity, and stronger inflammatory response than monocytes from age-matched control donors. Moreover, we observed that AD monocytes induce pro-inflammatory effects such as elevated astrocyte activation and neuronal apoptosis. Furthermore, the marked increase in IL1B and CCL3 expression underscores their pivotal role in AD monocyte-mediated neuroinflammation. Our findings provide insight into understanding monocytes’ role in AD pathogenesis, and our lab-compatible MPS models may offer a promising way for studying various neuroinflammatory diseases.
Understanding monocyte-driven neuroinflammation in Alzheimer’s disease using human brain organoid microphysiological systems
Tian, Chunhui , Ao, Zheng , Cerneckis, Jonas , Cai, Hongwei , Niu, Henyao, Kim, Jungsu , Kanekiyo, Takahisa , Kim, Jungsu , Kanekiyo, Takahisa , Chen, Lei , Niu, Henyao, Takayama, Kazuo , Shi, Yanhong , Gu, Mingxia , Guo, Feng

No container title available | February 21, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1101/2025.02.16.638539 Get It

Abstract Increasing evidence suggests that Alzheimer’s disease (AD) pathogenesis strongly correlates with neuroinflammation. Peripheral monocytes are crucial components of the human immune system that may play a role in neuroinflammation, but their contribution to AD pathogenesis is largely understudied partially due to the lack of appropriate human models. Here, we present human cortical organoid microphysiological systems (hCO-MPSs) for modeling dynamic AD neuroinflammation mediated by monocytes. By incorporating 3D printed devices into an existing cortical organoid protocol, 96 hCO-MPSs can be established with significantly reduced necrosis and hypoxia as well as enhanced viability within a commonly used 96 well plate, and each hCO-MPS consists of a doughnut-shaped hCO and a 3D printed device per well. Using this approach, monocytes from AD patients exhibit higher infiltration, decreased amyloid-beta (Aβ) clearance, and stronger inflammatory responses compared to monocytes from age-matched control donors. Moreover, pro-inflammatory effects such as elevated astrocyte activation and neuronal apoptosis were observed to be induced by AD monocytes. Furthermore, the significant increase in the expression of IL1B and CCL3, both at the transcriptional and protein levels, indicated the pivotal role of these cytokine and chemokine in monocyte-mediated AD neuroinflammation. Our findings provide insight for understanding monocytes’ role in AD pathogenesis, and the user-friendly MPS models we present are compatible with existing laboratory settings, highlighting their potential for modeling neuroinflammation and developing new therapeutics for various neuroinflammatory diseases.